ESMO's not what it used to be—and that's a good thing, executives say
admin 23rd October 2018 Uncategorised 0As the European Society for Medical Oncology meeting comes to a close, one thing is clear: ESMO isn’t the meeting it used to be. And the way biopharma executives see it, that’s a good thing.
More: ESMO's not what it used to be—and that's a good thing, executives say
Source: fierce